These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22280107)

  • 1. Positron emitting tracers in pre-clinical drug development.
    Fernandes E; Barbosa Z; Clemente G; Alves F; Abrunhosa AJ
    Curr Radiopharm; 2012 Apr; 5(2):90-8. PubMed ID: 22280107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography for modeling pathophysiological processes in vivo.
    Hendrikse NH; Luurtsema G; van der Veldt AA; Lubberink M
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):717-25. PubMed ID: 18729023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiopharmaceuticals in positron emission tomography: present situation and future perspectives.
    Olivas Arroyo C
    Radiologia; 2016; 58(6):468-480. PubMed ID: 27592111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging with SPECT as a tool for drug development.
    Gomes CM; Abrunhosa AJ; Ramos P; Pauwels EK
    Adv Drug Deliv Rev; 2011 Jun; 63(7):547-54. PubMed ID: 20933557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of pre-clinical PET imaging for drug development].
    Tsukada H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):231-7. PubMed ID: 22256612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomographic imaging in drug discovery.
    Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
    Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery.
    Zimmer L
    Expert Opin Drug Discov; 2024 Feb; 19(2):161-172. PubMed ID: 37948046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal tumor models for PET in drug development.
    Toyohara J; Ishiwata K
    Ann Nucl Med; 2011 Dec; 25(10):717-31. PubMed ID: 21879295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical molecular imaging with positron emission tomography.
    Saleem A; Charnley N; Price P
    Eur J Cancer; 2006 Aug; 42(12):1720-7. PubMed ID: 16797972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Twelve years' clinical experience in using positron emission tomography: advances and prospects].
    Granov AM; Tiutin LA; Kostenikov NA; Shtukovskiĭ OA; Mostova MI; Ryzhkova DV; Tlostanova MS; Stanzhevskiĭ AA; Balabanova AA; Panfilenko AA
    Vestn Rentgenol Radiol; 2008; (1):10-8. PubMed ID: 22187894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of molecular imaging in modern drug development.
    Cunha L; Szigeti K; Mathé D; Metello LF
    Drug Discov Today; 2014 Jul; 19(7):936-48. PubMed ID: 24434047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular tracers for the PET and SPECT imaging of disease.
    Pimlott SL; Sutherland A
    Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron Emission Tomography: applications in drug discovery and drug development.
    Wang J; Maurer L
    Curr Top Med Chem; 2005; 5(11):1053-75. PubMed ID: 16181131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.
    Pacilio M; Lauri C; Prosperi D; Petitti A; Signore A
    Semin Nucl Med; 2018 May; 48(3):261-276. PubMed ID: 29626943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET tracers based on (86)Y.
    Huang J; Cui L; Wang F; Liu Z
    Curr Radiopharm; 2011 Apr; 4(2):122-30. PubMed ID: 22191651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences.
    Coenen HH; Elsinga PH; Iwata R; Kilbourn MR; Pillai MR; Rajan MG; Wagner HN; Zaknun JJ
    Nucl Med Biol; 2010 Oct; 37(7):727-40. PubMed ID: 20870148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography applications in clinical neurology.
    Singhal T
    Semin Neurol; 2012 Sep; 32(4):421-31. PubMed ID: 23361486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor Occupancy Imaging Studies in Oncology Drug Development.
    Burvenich IJG; Parakh S; Parslow AC; Lee ST; Gan HK; Scott AM
    AAPS J; 2018 Mar; 20(2):43. PubMed ID: 29520671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.